(Q38836227)

6 September 2017

Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial (English)

1 reference

6 September 2017

0 references

Eric P Moll van Charante

1

1 reference

6 September 2017

Edo Richard

2

1 reference

6 September 2017

Lisa S Eurelings

3

1 reference

6 September 2017

Jan-Willem van Dalen

4

1 reference

6 September 2017

Suzanne A Ligthart

5

1 reference

6 September 2017

Emma F van Bussel

6

1 reference

6 September 2017

Marieke P Hoevenaar-Blom

7

1 reference

6 September 2017

Marinus Vermeulen

8

1 reference

6 September 2017

Willem A van Gool

9

1 reference

6 September 2017

language of work or name

English

0 references

publication date

26 July 2016

1 reference

6 September 2017

1 reference

6 September 2017

388

1 reference

6 September 2017

10046

1 reference

6 September 2017

797-805

1 reference

The global prevalence of dementia: a systematic review and metaanalysis

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

The Blackfriars Consensus on brain health and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Blood pressure and the prevention of cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning--the DANTE Study Leiden: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Treatment of hypertension in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

The Effect of Age on the Association Between Blood Pressure and Cognitive Function Later in Life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Cardiovascular risk management in community-dwelling elderly: opportunities for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Incidence of Dementia over Three Decades in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930950-3

7 January 2021

10.1016/S0140-6736(16)30950-3

Identifiers

DOI

1 reference

6 September 2017

1 reference